Literature DB >> 12951192

Ischemia/reperfusion-induced changes of hypothalamic-pituitary-adrenal (HPA) activity is opioid related in Sprague-Dawley rat.

Chi-Mei Hsueh1, Jon-Son Kuo, Sung-Fang Chen.   

Abstract

The interrelationship between the hypothalamic-pituitary-adrenal (HPA) activity and expression of central opioids is determined in ischemic Sprague-Dawley rats to support the therapeutic role of naloxone against cerebral ischemia. Two-month old rats received bilateral common carotid artery occlusion plus unilateral (right side) middle cerebral artery occlusion for 90 min under the anesthesia, and followed by reperfusion for various times. The plasma contents of adrenocorticotropin (ACTH) and RNA expression levels of proopiomelanocortin (POMC) were then determined in ischemic rats with or without naloxone treatment. Results showed that ischemia stimulates but reperfusion suppresses the activity of HPA axis. The induced expression of POMC at striatum and cortex areas appears to suppress the release of ACTH from the HPA axis. The suppression on the other hand is prevented by naloxone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951192     DOI: 10.1016/s0304-3940(03)00831-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  The involvement of central beta-endorphin in the cardioprotective effects of remote preconditioning mediated by the intracerebroventricular administration of morphine.

Authors:  X Cheng; Y E Zhang; X Lu; Y Lu; Z Chen
Journal:  Ir J Med Sci       Date:  2015-05-14       Impact factor: 1.568

Review 2.  Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2015-08-02       Impact factor: 3.996

3.  Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain.

Authors:  Chi-Hsin Lin; Chen-Hsuan Wang; Shih-Lan Hsu; Li-Ya Liao; Ting-An Lin; Chi-Mei Hsueh
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.